<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00833430</url>
  </required_header>
  <id_info>
    <org_study_id>IC006-99</org_study_id>
    <nct_id>NCT00833430</nct_id>
  </id_info>
  <brief_title>Avascular Necrosis (AVN) Long-Term Follow-up</brief_title>
  <official_title>Hedrocel Avascular Necrosis (AVN) Intervention Implant</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Zimmer Biomet</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Zimmer Biomet</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Long-term follow-up of IDE patients for publication&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This device (Hedrocel AVN Intervention Implant) was approved via 510(k) on April 15, 2005.&#xD;
      One site was left open to follow patients to 5 year follow-up for publication of device&#xD;
      survivorship.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <start_date>June 2006</start_date>
  <completion_date type="Actual">February 2013</completion_date>
  <primary_completion_date type="Actual">February 2013</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <primary_outcome>
    <measure>Safety, Efficacy and longevity of device with patient as opposed to conventional total hip replacement</measure>
    <time_frame>5 Year Follow-up</time_frame>
  </primary_outcome>
  <enrollment type="Actual">35</enrollment>
  <condition>Avascular Necrosis</condition>
  <condition>Femoral Head Collapse</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patients enrolled at investigational sites who had Stage I or Stage II Osteonecrosis of the&#xD;
        femoral head and who would qualify for core decompression based upon physical and&#xD;
        radiographic exam and medical history.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patient qualifies for core decompression based on physical exam&#xD;
&#xD;
          -  No history of core decompression&#xD;
&#xD;
          -  Patient is willing and able to provide written informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patient has been diagnosed as Stage 0, III, IV, V or VI using the Steinberg/UPenn&#xD;
             staging system.&#xD;
&#xD;
          -  Patient's BMI is &gt;40&#xD;
&#xD;
          -  Patient is mentally compromised&#xD;
&#xD;
          -  Patient has neurological condition in ipsilateral or contralateral limb, which affect&#xD;
             lower limb function&#xD;
&#xD;
          -  The patient has had a proximal femoral osteotomy or internal fixation in the affected&#xD;
             hip.&#xD;
&#xD;
          -  The patient has undergone previous treatment for AVN&#xD;
&#xD;
          -  Previous hip conditions&#xD;
&#xD;
          -  Patient's bone stock is insufficient&#xD;
&#xD;
          -  Patient has diagnosed systemic disease&#xD;
&#xD;
          -  Patient is a pregnant female&#xD;
&#xD;
          -  Patient is unable or unwilling to attend postop follow-up visits&#xD;
&#xD;
          -  Patient has received investigational drug within the previous 6 months or an&#xD;
             investigational device within the last 12 months&#xD;
&#xD;
          -  Patient has an active or latent infection&#xD;
&#xD;
          -  Patient has metal sensitivity&#xD;
&#xD;
          -  Patient is a prisoner&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Emory Orthopedic Clinic</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30329</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2016</verification_date>
  <study_first_submitted>January 28, 2009</study_first_submitted>
  <study_first_submitted_qc>January 29, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 2, 2009</study_first_posted>
  <last_update_submitted>February 18, 2016</last_update_submitted>
  <last_update_submitted_qc>February 18, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 19, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>AVN</keyword>
  <keyword>Femoral Head Collapse</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteonecrosis</mesh_term>
    <mesh_term>Necrosis</mesh_term>
    <mesh_term>Shock</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

